Analyst firms · Leerink Partners · TSVT
Leerink Partners TSVT price target and rating history
2seventy bio Inc. (TSVT) · Health Care
Leerink Partners rates 2seventy bio Inc. (TSVT) Outperform with a $18 price target, as of its latest action on Jan 31, 2024. It has published 3 rating actions on TSVT since February 2022, including 1 upgrade and 1 downgrade.
- Current rating
- Outperform
- Price target
- $18
- Median target, all firms
- Too few
- Actions on TSVT
- 3
Leerink Partners price target on TSVT
Every Leerink Partners rating on TSVT
- Jan 31, 2024
- Oct 30, 2023
- Feb 10, 2022
Questions about Leerink Partners and TSVT
- What is Leerink Partners's price target for TSVT?
- Leerink Partners's latest stated price target for 2seventy bio Inc. (TSVT) is $18, from its action on Jan 31, 2024.
- What is Leerink Partners's rating on TSVT?
- Leerink Partners rates TSVT Outperform, a bullish rating, as of Jan 31, 2024.
- When did Leerink Partners last change its view on TSVT?
- On Jan 31, 2024, Leerink Partners upgrades to Outperform from Market Perform, price target $5 to $18.
More TSVT rating histories
All Leerink Partners ratingsTSVT news and filingsEvery analyst firm
From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.